Companies / boyuan-new-materials-301617

Boyuan New Materials (301617)

ChinaTechnology & Electronics

Overview

Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. engages in the research and development, production, and sale of fine chemicals in China. It operates in four segments: Iodine Derivatives, Industrial Catalysts (precious metals), Organosilicon Series, and Chemiluminescent Materials. The company offers iodine derivatives, such as potassium iodide, sodium iodide, potassium iodate, hydriodic acid, copper iodide, and iodotrimethylsilane; and fine chemicals, including hexamethyldisilazane, hexameth

Employees748
Market Cap$9.1B
Revenue$1.5B
Listed OnShenzhen Stock Exchange
Ticker301617
CEOMr. Guoqing Yu
HeadquartersShouguang

Website

https://www.boyuanchemical.com